Stan Grof's Contributions to FDA Drug Development & Research with Psychedelics - Rick Doblin

Stanislav Grof's pioneering research on the human unconscious and his therapeutic approach to psychedelics provided the foundational framework for MAPS. His emphasis on the inner healer and the necessity to experience, rather than suppress, turbulent states has heavily influenced current psychiatric protocols. Rick Doblin explores how Grof's scientific rigor and insistence on the value of both clinical and non-clinical practice provided the moral and strategic roadmap for navigating drug policy. By maintaining a focus on therapeutic integrity and a longitudinal study model, MAPS has pursued the medicalization of mdma and other substances as tools that act for psychiatry similarly to how a telescope functions in astronomy.